These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20428424)

  • 1. The Prognostic Factors for Patients with pT1a Renal Cell Carcinoma.
    Kim JM; Song PH; Kim HT; Park TC
    Korean J Urol; 2010 Apr; 51(4):233-8. PubMed ID: 20428424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma.
    Ito K; Seguchi K; Shimazaki H; Takahashi E; Tasaki S; Kuroda K; Sato A; Asakuma J; Horiguchi A; Asano T
    Oncol Lett; 2015 Jan; 9(1):125-130. PubMed ID: 25435945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma.
    Cho DS; Kim SI; Choo SH; Jang SH; Ahn HS; Kim SJ
    Scand J Urol; 2016 Jun; 50(3):186-91. PubMed ID: 26878156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
    Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of tumor volume on survival in patients with renal cell carcinoma.
    Seçil M; Çullu N; Aslan G; Mungan U; Uysal F; Tuna B; Yörükoğlu K
    Diagn Interv Radiol; 2012; 18(5):480-7. PubMed ID: 22618630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
    Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
    BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
    Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T
    BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.
    Cho MC; Kim JK; Moon KC; Kim HH; Kwak C
    Int Braz J Urol; 2013; 39(3):353-63. PubMed ID: 23849567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Preoperative Prognostic Nutritional Index in Patients Undergoing Nephrectomy for Nonmetastatic Renal Cell Carcinoma.
    Kim SJ; Kim SI; Cho DS
    Am J Clin Oncol; 2020 Jun; 43(6):388-392. PubMed ID: 32079852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Microvascular Invasion and Tumor Necrosis on the Prognosis of Korean Patients with pT1b Renal Cell Carcinoma.
    Kwon SY; Lee JN; Kim BS; Ko YH; Song PH; Kim HT; Kim TH; Yoo ES; Choi GS; Kim BW; Kwon TG
    Urol Int; 2015; 95(1):65-71. PubMed ID: 25413438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unclassified renal cell carcinoma: a report of 56 cases.
    Lopez-Beltran A; Kirkali Z; Montironi R; Blanca A; Algaba F; Scarpelli M; Yorukoglu K; Hartmann A; Cheng L
    BJU Int; 2012 Sep; 110(6):786-93. PubMed ID: 22404824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
    Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
    Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in renal cell carcinoma: A single‑center study.
    Ali RM; Muhealdeen DN; Fakhralddin SS; Bapir R; Tahir SH; Rashid RJ; Omer CS; Abdullah HO; Abdalla BA; Mohammed SH; Kakamad FH; Abdullah F; Karim M; Rahim HM
    Mol Clin Oncol; 2023 Sep; 19(3):66. PubMed ID: 37614366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of nuclear grade and tumor size in Korean patients with chromophobe renal cell carcinoma: a comparison with conventional renal cell carcinoma.
    Ku JH; Moon KC; Kwak C; Kim HH
    Urol Oncol; 2011; 29(5):487-91. PubMed ID: 19767221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of AST/ALT (De Ritis) ratio on survival and its relation to tumor histopathological variables in patients with localized renal cell carcinoma.
    Canat L; Ataly HA; Agalarov S; Alkan I; Altunrende F
    Int Braz J Urol; 2018; 44(2):288-295. PubMed ID: 29211398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.